Ritrosulfan

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530279

CAS#: 4148-16-7

Description: Ritrosulfan is an Antineoplastic Agent.

Chemical Structure

img
Ritrosulfan
CAS# 4148-16-7
Instruction

Theoretical Analysis

MedKoo Cat#: 530279
Name: Ritrosulfan
CAS#: 4148-16-7
Chemical Formula: C10H22N2O10S22-
Exact Mass: 394.07
Molecular Weight: 394.411
Elemental Analysis: C, 30.45; H, 5.62; N, 7.10; O, 40.56; S, 16.26

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Ritrosulfan

IUPAC/Chemical Name: 1,4-Dideoxy-1,4-bis((2-hydroxyethyl)amino)erythritol 1,4-dimethanesulfonate (ester)

InChi Key: FLKYKLXEGVMXSW-OXYCZDQYSA-L

InChi Code: InChI=1S/C10H24N2O10S2/c13-3-1-11-7(5-23(17,18)19)9(15)10(16)8(12-2-4-14)6-24(20,21)22/h7-16H,1-6H2,(H,17,18,19)(H,20,21,22)/p-2/t7?,8?,9-,10+

SMILES Code: O[C@H]([C@@H](C(CS(=O)([O-])=O)NCCO)O)C(CS(=O)([O-])=O)NCCO

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 394.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Korda J, Genti G, Káli G, Bálint G, Bátory G. Successful treatment of respiratory failure associated with dermatomyositis. J Rheumatol. 1987 Oct;14(5):1075-6. PubMed PMID: 3323507.

2: Zárandy B, Szabó J, Molnár I, Sallai Z, Simon Z, Légrády J. [Recurrence prevention of papillomas of the bladder using lycurim instillation]. Z Urol Nephrol. 1984 Oct;77(10):599-603. German. PubMed PMID: 6549094.

3: Ban J. [Lycurim in combined chemotherapy in vitro]. Lijec Vjesn. 1984 Sep;106(9):374-8. Croatian. PubMed PMID: 6548786.

4: Kliuchanskaia NV, Iliukhin AV, Kiselev AV. [Evaluation of the therapeutic effectiveness of likurim in lymphosarcoma in dogs]. Gematol Transfuziol. 1984 Aug;29(8):46-9. Russian. PubMed PMID: 6548198.

5: Klener P. [Lycurim, lymphomas and cytostatic trials]. Vnitr Lek. 1984 Jul;30(7):714-6. Czech. PubMed PMID: 6388153.

6: Hegedüs L, Kerpel-Fronius S, Horváth IP, Hindy I, Eckhardt S. A sensitive assay for the pharmacokinetic investigation of a rapidly hydrolyzing alkylating agent Lycurim (ritrosulfan; R-74; NSC-122 402). Eur J Cancer Clin Oncol. 1984 Jul;20(7):933-8. PubMed PMID: 6086356.

7: Pál K, Kopper L, Lapis K. Chemotherapeutic sensitivity of liver metastases from intrasplenically-growing Lewis lung tumor. Clin Exp Metastasis. 1983 Oct-Dec;1(4):341-7. PubMed PMID: 6443744.

8: Kondás J, Szentgyörgyi E. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours. Ther Hung. 1983;31(2):55-8. PubMed PMID: 6571182.

9: Lui MS, Jackson RC, Harkrader RJ, Weber G. Rat hepatomas: chemotherapy with lycurim and pyrazofurin. J Natl Cancer Inst. 1982 Apr;68(4):665-8. PubMed PMID: 6951080.

10: Ban J, Olah E, Werber G. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture. Cancer Treat Rep. 1982 Feb;66(2):343-9. PubMed PMID: 6895716.

11: Klener P. Lycurim (NSC 122402) in the treatment of chronic lymphocytic leukemia. Neoplasma. 1982;29(1):87-92. PubMed PMID: 6896084.

12: Kerpel-Fronius S. Hungarian anticancer drugs (antineoplastics). Ther Hung. 1982;30(3):110-21. Review. PubMed PMID: 6095482.

13: Vygovskaya YI, Loginsky VE, Vorobel AV, Kondratieva NA, Mazurok AA, Korotky VV, Kotsay BR. Lycurim (R-74) in the therapy of chronic lymphocytic leukaemia. Haematologia (Budap). 1981 Dec;14(4):399-405. PubMed PMID: 6178656.

14: Kotlarek-Haus S, Frydecka I, Gatazka Z, Gabryś K. Evaluation of the therapeutic effect of lycurim in lymphoma. Ther Hung. 1981;29(3):124-7. PubMed PMID: 6897914.

15: Janicki K, Skotnicki AS, Blicharski J, Kwiatkowski A, Sliwczyńska-Dura B, Lisiewicz J. [Lycurim in the treatment of patients with chronic lymphocytic leukemia (author's transl)]. Przegl Lek. 1980;37(4):429-35. Polish. PubMed PMID: 6996043.

16: Kerpel-Fronius S, Csetényi J, Hegedüs L, Horváth IP, Ringwald G, Töttössy B, Eckhardt S. Chemical reactivity and intracavitary application of alkylating sugar alcohol derivatives. Oncology. 1980;37 Suppl 1:109-14. PubMed PMID: 6893858.

17: Stoychkov JN, Milushev AS, Todorov DK. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim. Neoplasma. 1980;27(1):33-6. PubMed PMID: 6892839.